Published Date:2021-02-02 Original Link:https://www.onenessbio.com/en/news_detail25_4.htm No 1 Date of announcement 2021/02/02 Time of announcement  21:33:43 Subject Oneness Biotech Co.,LTD receives a U.S. patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on the developing new drug: ON101 Cream.      To which item it meets paragraph 53 Date of events 2021/02/02 Statement 1.Date of occurrence of the...Read More

Published Date:2021-01-29 Original Link:https://www.onenessbio.com/en/news_detail24_4.htm No 2 Date of announcement  2021/01/29 Time of announcement        18:56:05 Subject Oneness Biotech Co.,LTD receives a European patent on antagonistic PDL1 aptamers.      To which item it meets paragraph 53 Date of events       2021/01/29 Statement 1.Date of occurrence of the event:2021/01/29 2.Company name:ONENESS BIOTECH CO., LTD....Read More

Published Date:2021-01-29 Original Link:https://www.onenessbio.com/en/news_detail23_4.htm No 1 Date of announcement  2021/01/29 Time of announcement       18:54:40 Subject Oneness Biotech Co.,LTD receives a European patent on antagonistic CTLA-4 aptamers.      To which item it meets paragraph 53 Date of events       2021/01/29 Statement 1.Date of occurrence of the event:2021/01/29 2.Company name:ONENESS BIOTECH CO., LTD....Read More

Published Date:2021-01-14 Original Link:https://www.onenessbio.com/en/news_detail22_4.htm No 1 Date of announcement   2021/01/14 Time of announcement  17:17:29 Subject Oneness announces that LEO PHARMA made the 2nd upfront payment of US$15.12MM according to the agreement. A total of US$33.6MM upfront payments have been received.       To which item it meets paragraph 53 Date of events     ...Read More

Published Date:2021-01-04 Original Link:https://www.onenessbio.com/en/news_detail75_4.htm No 1 Date of announcement  2021/01/04 Time of announcement 19:29:48 Subject Oneness Biotech to Present at the 39th Annual J.P. Morgan Healthcare Conference      To which item it meets paragraph 12 Date of events       2021/01/11 Statement 1.Date of institutional investor conference: 2021/01/11 2.Time of institutional investor conference: 22:15...Read More

Published Date:2020-12-16 Original Link:https://www.onenessbio.com/en/news_detail74_1.htm No 1 Date of announcement 2020/12/16 Time of announcement  17:20:11 Subject Announcement by Oneness on Nanchou Manufacturing Site Receiving GMP Certification from TFDA on Manufacturing Active Pharmaceutical Ingredient      To which item it meets paragraph 53 Date of events 2020/12/16 Statement 1.Date of occurrence of the event:2020/12/16 2.Company name:Oneness Biotech...Read More

Published Date:2020-11-18 Original Link:https://www.onenessbio.com/en/news_detail73_1.htm No 1 Date of announcement 2020/11/18 Time of announcement 15:05:22 Subject Time Adjustment on Oneness Bio’s Oral Presentation Time Slot at EWMA 2020 Online Conference      To which item it meets paragraph 53 Date of events 2020/11/18 Statement 1.Date of occurrence of the event:2020/11/18 2.Company name:Oneness Biotech Co., Ltd. 3.Relationship...Read More

Published Date:2020-11-11 Original Link:https://www.onenessbio.com/en/news_detail72_1.htm No 1 Date of announcement 2020/11/11 Time of announcement 18:25:13 Subject Oral presentation by Oneness Biotech at EWMA 2020 virtual conference on ON101 global Phase 3 MRCT results.      To which item it meets paragraph 12 Date of events 2020/11/11 Statement  1.Date of institutional investor conference: 2020/11/18 2.Time of institutional...Read More

Published Date:2020-11-05 Original Link:https://www.onenessbio.com/en/news_detail71_1.htm No 1 Date of announcement 2020/11/05 Time of announcement 19:15:48 Subject Oneness submits an IND to TFDA on a phase II clinical trial of FB704A, a mAb developed from its own platform, for treating severe neutrophilic asthma.      To which item it meets paragraph 10 Date of events 2020/11/05 Statement...Read More

Published Date:2020-11-02 Original Link:https://www.onenessbio.com/en/news_detail70_1.htm No 1 Date of announcement 2020/11/02 Time of announcement  21:01:47 Subject Oneness Biotech Co., LTD. receives a Mexican patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101).      To which item it meets paragraph 53 Date of events 2020/11/02 Statement 1.Date of occurrence of the...Read More